Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RYVU Therapeutics S.A. Director's Dealing 2022

Dec 22, 2022

5798_rns_2022-12-22_f6534de3-c39e-4479-a4d2-d135cc41b5d5.html

Director's Dealing

Open in viewer

Opens in your device viewer

The ManagementBoard of Ryvu Therapeutics S.A. with its registered office in Krakow,Poland (_quot;Company_quot;, _quot;Issuer_quot;) hereby informsthat the Company received a notification prepared in accordance withArticle 19.1 of MAR from Mr. Paweł Przewięźlikowski as from a persondischarging managerial responsibilities in the Company, due to theseries J shares allotment. The notification is attached to this report.